MRSA

:   Methicillin-resistant *[Staphylococcus aureus](http://dx.doi.org/10.1601/nm.11043)*

Introduction
============

Antibiotic resistance in *[S. aureus](http://dx.doi.org/10.1601/nm.11043)* is a major concern, as an increasing number of infections are caused by methicillin-resistant *[S. aureus](http://dx.doi.org/10.1601/nm.11043)* (MRSA). [Figure 1](#f1){ref-type="fig"} shows the phylogenetic position of *[S. aureus](http://dx.doi.org/10.1601/nm.11043)* in relation to other staphylococci. In Malaysia, the incidence of MRSA-related infections is a cause of concern in hospitals country-wide. Health-associated MRSA (HA-MRSA) has been dominated by a few lineages in Southeast Asia, particularly ST239. Sequence type 239 is an international healthcare-associated (HA) MRSA lineage prevalent in Asia, South America and Eastern Europe, which includes EMRSA-1, -4, -7, and -11 and the Brazilian, Portuguese, Hungarian, and Viennese clones. Strains of type ST239 are typically resistant to multiple classes of antibiotics and antiseptics such as β-lactam antibiotics.

![Phylogenetic tree highlighting the position of *[Staphylococcus aureus](http://dx.doi.org/10.1601/nm.11043)* strain PR01 relative to other type strains within the *[Staphylococcaceae](http://dx.doi.org/10.1601/nm.5229)*. The strains and their corresponding GenBank accession numbers for 16S rRNA genes are: *[S. aureus](http://dx.doi.org/10.1601/nm.11043)* strain ATCC 12600, L36472; *[S. saprophyticus](http://dx.doi.org/10.1601/nm.11051)* strain ATCC 15305, AP008934; *[S. epidermidis](http://dx.doi.org/10.1601/nm.5246)* strain ATCC 14990, D83363; *[S. hominis](http://dx.doi.org/10.1601/nm.11049)* strain DSM 20328, X66101; *[S. haemolyticus](http://dx.doi.org/10.1601/nm.5252)* strain CCM2737, X66100; and *[S. cohnii](http://dx.doi.org/10.1601/nm.11046)* strain ATCC 49330, AB009936. The tree uses sequences aligned by the RDP aligner, and uses the Jukes-Cantor corrected distance model to construct a distance matrix based on alignment model positions without the use of alignment inserts, and uses a minimum comparable position of 200. The tree is built with RDP Tree Builder, which uses Weighbor \[[@r1]\] with an alphabet size of 4 and length size of 1000. The building of the tree also involves a bootstrapping process repeated 100 times to generate a majority consensus tree \[[@r2]\]. *[Staphylococcus lutrae](http://dx.doi.org/10.1601/nm.5261)* (X84731) was used as an outgroup.](sigs.3887716-f1){#f1}

Classification and features
===========================

We have chosen a representative of an MRSA strain, termed MRSA PR01 isolated from a patient with septicemia, isolated from a hospital in Kuala Lumpur. [Table 1](#t1){ref-type="table"} indicates general information gathered on MRSA PR01. The MRSA PR01 strain has been identified as sequence type 239 (ST239) by multilocus sequence typing (MLST). Initial disc susceptibility tests showed that the strain is resistant to β-lactam antibiotics oxacillin, ampicillin, cefuroxime, ceftriaxone, gentamicin, erythromycin, ciprofloxacin and co-trimoxazole.

###### Classification and general features of *[Staphylococcus aureus](http://dx.doi.org/10.1601/nm.11043)* MRSA PR01

  -----------------------------------------------------------------------------------------------------------------------------------------------------------
  **MIGS ID**         **Property**                       **Term**                                                                      **Evidence code**^a^
  ------------- ---------------------------------- ------------------------------------------------------------------------------ ---------------------------
                      Current classification             Domain *Bacteria*\                                                             \[[@r3]\]\
                                                         Phylum *[Firmicutes](http://dx.doi.org/10.1601/nm.3874)*\                      \[[@r4]-[@r7]\]\
                                                         Class *[Bacilli](http://dx.doi.org/10.1601/nm.4854)*\                          \[[@r8],[@r9]\]\
                                                         Order *[Bacillales](http://dx.doi.org/10.1601/nm.4855)*\                       \[[@r6],[@r10]\]\
                                                         Family *[Staphylococcaceae](http://dx.doi.org/10.1601/nm.5229)*\               \[[@r9],[@r11]\]\
                                                         Genus *[Staphylococcus](http://dx.doi.org/10.1601/nm.5230)*\                   \[[@r6],[@r12]\]\
                                                         Species *[Staphylococcus aureus](http://dx.doi.org/10.1601/nm.11043)*\         \[[@r6],[@r12]\]\
                                                         Type strain MRSA PR01                                                         TAS

                      Gram stain                         Positive                                                                      TAS

                      Cell shape                         Coccus                                                                        TAS

                      Motility                           Non-motile                                                                    TAS

                      Sporulation                        Non-sporulating                                                               TAS

                      Temperature range                  Mesophile                                                                     TAS

                      Optimum temperature                30-37°C                                                                       TAS

                      Carbon source                      Glucose                                                                       TAS

                      Energy source                      Chemoorganotrophic                                                       

                      Terminal electron receptor                                                                                  

  MIGS-6              Habitat                            Human respiratory tract, skin                                                 TAS

  MIGS-6.3            Salinity                                                                                                    

  MIGS-22             Oxygen                             Facultative anaerobe                                                          TAS

  MIGS-15             Biotic relationship                                                                                         

  MIGS-14             Pathogenicity                      Opportunistic pathogen                                                        TAS

  MIGS-4              Geographic location                Malaysia                                                                      IDA

  MIGS-5              Sample collection time             May 2009                                                                      IDA

  MIGS-4.1            Latitude                           4.1936°N                                                                      IDA

  MIGS-4.2            Longitude                          103.7249°E                                                                    IDA

  MIGS-4.3            Depth                              Not reported                                                                  IDA

  MIGS-4.4            Altitude                           Not reported                                                                  IDA
  -----------------------------------------------------------------------------------------------------------------------------------------------------------

a\) Evidence codes - IDA: Inferred from Direct Assay; TAS: Traceable Author Statement (i.e., a direct report exists in the literature); NAS: Non-traceable Author Statement (i.e., not directly observed for the living, isolated sample, but based on a generally accepted property for the species, or anecdotal evidence). These evidence codes are from the Gene Ontology project \[[@r13]\].

Genome sequencing information
=============================

Genome project history
----------------------

This organism was selected for sequencing as a representative of MRSA infection in a local Malaysian hospital. The genome sequences of this organism were deposited in GenBank (WGS database). Sequencing, finishing and annotation were performed at the Integrative Pharmacogenomics Centre (PROMISE), UiTM. [Table 2](#t2){ref-type="table"} presents the project information and its association with MIGS version 2.0 compliance \[[@r14]\].

###### Project information

  **MIGS ID**        **Property**                   **Term**
  ------------- ------------------------------ -----------------------------------------------
  MIGS-31            Finishing quality              Non-contiguous Finished
  MIGS-28            Libraries used                 One 350bp Illumina GAIIx genomic library
  MIGS-29            Sequencing platforms           Illumina GAIIx, Sanger
  MIGS-31.2          Fold coverage                  \>200×
  MIGS-30            Assemblers                     CLCBio Genomics Workbench
  MIGS-32            Gene calling method            Glimmer and GeneMark
                     Genome Database release        DDBJ/EMBL/Genbank/
                     Genbank ID                     ANPO01000000
                     Genbank Date of Release        January 11, 2014
                     GOLD ID                   
                     Project relevance              Medical, Tree of life

Growth conditions and DNA isolation
-----------------------------------

MRSA PR01 was grown overnight under aerobic conditions in Tryptic Soy Broth at 37°C. DNA extraction was performed using MasterPure™ Gram Positive DNA Purification Kit (Epicentre, Madison, USA) as per manufacturer\'s instructions. The concentration and purity of resultant DNA was assessed by UV spectrophotometry (Nanodrop, Thermo Scientific). 5 µg of genomic DNA (A~260/280~ = 1.88) was used for library preparation.

Genome sequencing and assembly
------------------------------

The genome sequence was obtained using 104 Mb of paired-end (300 bp spacing) data from the Illumina GA*II~x~* platform (Illumina, San Diego, CA) with 36-bp reads. Sequence data were assembled using CLCBio Genomics Workbench (CLC bio, Aarhus, Denmark). One hundred and ninety-five contigs (N50: 13,272 bp) were generated, and were overlaid with the reference sequence Mu50 using OSLay. Fourteen supercontigs were generated as a result. Gaps were closed using Sanger sequencing.

Genome annotation
-----------------

The genome was annotated using BASys \[[@r15]\] and RAST \[[@r16]\].

Genome properties
=================

The MRSA PR01 genome consists of a 2,725,110-bp circular chromosome with a GC content of 32.6% ([Table 3](#t3){ref-type="table"}). The MRSA PR01 genome contains 2668 CDs with 19 rRNA features (). A total of 1722 (64.5%) of protein coding genes were assigned to COGs, and a breakdown of the functional assignment of COG-assigned genes is shown in [Table 4](#t4){ref-type="table"}. Plasmid sequences were only partially sequenced. [Figure 2](#f2){ref-type="fig"} depicts genomic regions of interest found in the preliminary analysis of the MRSA PR01 genome.

###### Nucleotide content and gene count levels of the MRSA PR01 genome

  Attribute                      Value              % of total^a^
  ------------------------ ----------------- ----------------------
  Genome size (bp)               2,725,110   
  DNA G+C content (bp)           888,386            32.6
  Total genes                    2687        
  RNA genes                      19                 0.7
  Protein-coding genes           2668               99.3
  Genes assigned to COGs         1722               64.5

a\) The total is based on either the size of the genome in base pairs or the total number of protein coding genes in the annotated genome.

###### Number of genes associated with the 25 general COG functional categories

  **Code**       **Value**       **%age**^a^        **Description**
  ---------- --------------- ----------------- -------------------------------------------------------------------
  J              140             5.247              Translation
  A              -               -                  RNA processing and modification
  K              127             4.760              Transcription
  L              126             4.723              Replication, recombination and repair
  B              -               -                  Chromatin structure and dynamics
  D              23              0.862              Cell cycle control, mitosis and meiosis
  Y              -               -                  Nuclear structure
  V              -               -                  Defense mechanisms
  T              47              1.762              Signal transduction mechanisms
  M              91              3.411              Cell wall/membrane biogenesis
  N              4               0.150              Cell motility
  Z              0               0                  Cytoskeleton
  W              0               0                  Extracellular structures
  U              0               0                  Intracellular trafficking and secretion
  O              72              2.699              Posttranslational modification, protein turnover, chaperones
  C              106             3.973              Energy production and conversion
  G              129             4.835              Carbohydrate transport and metabolism
  E              186             6.972              Amino acid transport and metabolism
  F              68              2.549              Nucleotide transport and metabolism
  H              83              3.111              Coenzyme transport and metabolism
  I              62              2.324              Lipid transport and metabolism
  P              123             4.610              Inorganic ion transport and metabolism
  Q              23              0.862              Secondary metabolites biosynthesis, transport and catabolism
  R              193             7.234              General function prediction only
  S              119             4.460              Function unknown
  \-             946             35.457             Not in COGs

a\) The total is based on the total number of protein coding genes in the annotated genome.

![Visual representation of the MRSA PR01 genome. From outer to inner tracks: Scale (in bases); annotated CDSs colored according to predicted function (refer to legend); forward strand CDS; reverse strand CDS; GC skew.](sigs.3887716-f2){#f2}

Initial analysis of the genome revealed several key features. This genome has a typical SCCmec type III cassette, containing cadmium resistance genes. SCCmec type III is a composite element that is comprised of SCCmec and SCCmercury. In the MRSA PR01 genome, like others, this region harbors *ccrC*, pI258 and Tn554 as well as the genes involved in cadmium resistance. The MRSA PR01 genome contains two pathogenicity islands, and several resistance features were identified such as the *qacA* gene, which confers resistance to antiseptics such as cationic biocides, quaternary ammonium salts, and diamidines via an export-mediated mechanism, and the *norA* gene which confers resistance to hydrophilic quinolones such as norfloxacin and ciprofloxacin. There were 9 regions defined as prophage regions by PHAST \[[@r17]\] with one complete prophage region.

Conclusion
==========

This study is the first to report on the whole genome sequence of a Malaysian MRSA isolate. Preliminary analysis of the genome has highlighted the genetic determinants that are responsible for the organism to adapt easily to selective pressures. Further research is being conducted to provide insight on the adaptive power of this healthcare-associated strain to attain high resistance to antibiotics.

*Nucleotide sequence accession numbers*. This Whole Genome Shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession ANPO00000000. The version described in this paper is the first version, ANPO01000000.
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